From April 1, 2024 to April 30, 2024, the company has repurchased 100 shares, representing 0.000029% for CNY 0.001688 million. With this, the company has completed the repurchase of 1,646,420 shares, representing 0.48% for CNY 27.79 million under the buyback announced on January 24, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.83 CNY | -0.34% | -3.67% | -17.87% |
31/05 | Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces Dividend Implementation for 2023, Payable on 06 June 2024 | CI |
06/05 | China Approves Tianyu Pharma's Heart Medication | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.87% | 844M | |
+20.20% | 43.77B | |
+28.27% | 22.83B | |
+20.25% | 15.56B | |
+19.35% | 14.34B | |
+54.98% | 12.96B | |
-0.05% | 6.79B | |
-12.16% | 6.41B | |
-8.87% | 5.73B | |
+14.65% | 5.69B |
- Stock Market
- Equities
- 300702 Stock
- News Zhejiang Tianyu Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 24, 2024.